Cytek Biosciences, Inc. (CTKB) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US23285D1090
Cytek Biosciences, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 201.49 m USD |
| Gross profit | 104.46 m USD |
| Operating income | -40.38 m USD |
| EBIT | -31.58 m USD |
| Net income | -66.54 m USD |
| Diluted EPS – continuing operations | -0.52 USD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Cytek Biosciences, Inc.
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
More stocks
- Lingda Group Co Ltd (300125.SZ)
- Metalla Royalty & Streaming Ltd (MTA.V)
- Evertz Technologies Limited (ET.TO)
- Community West Bancshares (CWBC)
- FOX FACTORY HOLDING CORP (FOXF)
- Fujian Minfa Aluminium Co Ltd (002578.SZ)
- Tong Oil Tools (300164.SZ)
- Endur ASA (ENDUR.OL)
- HORIZON FIXTURE GROUP CO LTD (6957.TW)
- MOVADO GROUP INC (MOV)
- Talamore Mining Corp. (TALA.TO)
- Toyo Engineering Corp (6330.T)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.